Abstract
Drugs and other chemicals may produce qualitatively and quantitatively different toxicologic effects in embryos, fetuses and newborns than in the adult of the same species. When such toxicity occurs during embryogenesis congenital malformations may result. On the other hand, agents which produce toxicity during late fetal development, or during the neonatal period, may impair development or produce toxicity qualitatively similar to that seen in the adult. During embryogenesis there are embryological and non-embryological factors which determine an organism’s susceptibility to an agent, such as the nature of the agent, the dose, and maternal physiology (Wilson, 1965). Agents which disrupt embryonic development may initially act at any of the processes essential for normal development, e.g., cell division, differential gene expression, changes in the surface properties and shapes of cells, or general cellular metabolism. Most organs have a period of particular susceptibility to teratogens which probably coincides with the early and critical developmental events for that organ. During the fetal and neonatal period, however, after differentiation of cells is largely completed, chemical toxicity may involve interference with cell growth.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Brock, N. and Hohorst, H.-J.: Ueber die Aktivierung von Cyclophosphamide in vivo und in vitro. Arzneimittel-Forschung 13: 1021–1031, 1963.
Brock, N. and Hohorst, H.-J.: Metabolism of cyclophosphamide. Cancer 20: 900–904, 1967.
Bus, J.S., Short, R.D. and Gibson, J.E.: Effect of phenobarbital and SKF-525A on the toxicity, elimination and metabolism of cyclophosphamide in newborn mice. J. Pharmacol. Exp. Ther. 184: 749–756, 1973.
Cohen, J.L. and Jao, J.J.: Enzymatic basis of cyclophosphamide activation by hepatic microsomes of the rat. J. Pharmacol. Exp. Ther. 174: 206–210, 1970.
Conney, A.H.: Pharmacological implications of microsomal enzyme induction. Pharmacol. Rev. 19: 317–366, 1967.
Conners, T.A., Grover, P.L. and McLoughlin, A.M.: Micro-somal activation of cyclophosphamide in vivo. Biochem. Pharmacol. 19: 1533–1535, 1970.
Fields, R.B., Gang, M., Kline, I., Venditti, J.M. and Waravdekar, V.S.: The effect of phenobarbital or 2diethylaminoethyl-2, 2-diphenylvalerate on the activation of cyclophosphamide in vivo. J. Pharmacol. Exp. Ther. 180: 475–483, 1972.
Fouts, J.R.: Some studies and comments on hepatic and extra-hepatic microsomal toxication-detoxication systems. Environmental Health Perspectives: experimental issue. 2: 55–66, 1972.
Fouts, J.R. and Adamson, R.H.: Drug metabolism in the newborn rabbit. Science (Washington) 129: 857–858, 1959.
Fouts, J.R. and Devereux, T.R.: Developmental aspects of hepatic and extrahepatic drug-metabolizing enzyme systems: Microsomal enzymes and components in rabbit liver and lung during the first month of life. J. Pharmacol. Exp. Ther. 183: 458–468, 1972.
Gerlinger, P.: Action du cyclophosphamide injecté à la mére sur la réalisation de la forme du corps des embryons de lapin. C. R. Seances Soc. Biol. Filiales 158: 2154–157, 1964.
Gibson, J.E. and Becker, B.A.: Effect of phenobarbital and SKF-525A on the teratogenicity of cyclophosphamide in mice. Teratology 1: 393–398, 1968.
Gibson, J.E. and Becker, B.A.: The teratogenicity of cyclo- phosphamide in mice. Cancer Res. 28: 475–480, 1968.
Gibson, J.E. and Becker, B.A.: Effect of phenobarbital and SKF-525A on placental transfer of cyclophosphamide in mice. J. Pharmacol. Exp. Ther. 177: 256–262, 1971.
Gibson, J.E. and Becker, B.A.: Teratology of structural truncates of cyclophosphamide in mice. Teratology 4: 141–151, 1971.
Goldenthal, E.I.: A compilation of LD50 values in newborn and adult animals. Toxicol. Appl. Pharmacol. 18: 185–207, 1971.
Hackenberger, I., Kreybig, T. von: Vergleichende teratologische Untersuchungen bei der Maus und der Ratte. Arzneimittel-Forschung 15: 1456–1460, 1965.
Hart, L.G., Adamson, R.H., Dixon, R.L. and Fouts, J.R.: Stimulation of hepatic microsomal drug metabolism in the newborn and fetal rabbit. J. Pharmacol. Exp. Ther. 137: 103–106, 1962.
Hayes, F.D., Short, R.D. and Gibson, J.E.: A correlation between cyclophosphamide induced leukopenia in mice and the presence of alkylating metabolites. Proc. Soc. Exp. Biol. Med. 139: 417–421, 1972.
Henderson, P.T.: Metabolism of drugs in rat liver during the perinatal period. Biochem. Pharmacol. 20: 1225–1232, 1971.
Hill, D.L., Laster, W.R., Jr. and Struck, R.F.: Enzymatic metabolism of cyclophosphamide and nicotine and production of a toxic cyclophosphamide metabolite. Cancer Res. 32: 658–665, 1972.
Jondorf, W.R., Maickel, R.P. and Brodie, B.B.: Inability of newborn mice and guinea pigs to metabolize drugs. Biochem. Pharmacol. 1: 352–354, 1959.
Kreybig, T. von: Die teratogene Wirkung von Cyclophosphamide wahrend der embryonalen Entwicklungsphase bei der Ratte. Naunyn-Schmeidegergs Arch. Pharmakol. 252: 173–195, 1965.
MacLeod, S.M., Renton, K.W. and Eade, N.R. Development of hepatic microsomal drug-oxidizing enzymes in immature male and female rats. J. Pharmacol. Exp. Ther. 183: 489–498, 1972.
Murphy, M.L.: Teratogenic effects of growth inhibiting chemicals, including studies on thalidomide. Clin. Proc. Child. Hosp. D.C. 18: 307–322, 1962.
Rauen, H.M. and Kramer, K.P.: Der Gesamtalkylantien Blutspiegel von Ratten nach Verabreichung von Cyclophosphamid and Acyclophosphamid. Arzneimittel-Forschung 14: 1066–1067, 1964.
Roberts, J.J., Brent, T.P. and Crathorn, A.R.: The mechanism of the cytotoxic action of alkylating agents on mammalian cells. In P. N. Campbell (ed.), The Interaction of Drugs and Subcellular Components in Animal Cells, pp. 5–27, London: J. & A. Churchill, Ltd., 1968.
Shoji, R. and Ohzu, E.: Effect of endoxan on developing mouse embryos. J. Fac. Sci. Hokkaido Univ. Serv. VI Zool. 15: 662–665, 1965.
Short, C.R. and Davis, L.E.: Perinatal development of drug- metabolizing enzyme activity in swine. J. Pharmacol. Exp. Ther. 174: 185–196, 1970.
Short, R.D. and Gibson, J.E.: Development of cyclophosphamide activation and its implications in perinatal toxicity to mice. Toxicol. Appl. Pharmacol. 19: 103–110, 1971.
Short, R.D. and Gibson, J.E.: The effects of cyclophosphamide and nor-nitrogen mustard administration to one-day-old mice. Experientia (Basel) 27: 805–806, 1971.
Short, R.D., Rao, K.S. and Gibson, J.E.: The in vivo biosynthesis of DNA, RNA, and proteins by mouse embryos after a teratogenic dose of cyclophosphamide. Teratology 6: 129–137, 1972.
Short, R.D. and Gibson, J.E.: Biosynthesis of deoxyribonucleic acid, ribonucleic acid and protein in vivo by neonatal mice after a toxic dose of cyclophosphamide. Biochem. Pharmacol. 22: 3181–3188, 1973.
Sladek, N.E.: Therapeutic efficacy of cyclophosphamide as a function of its metabolism. Canc. Res. 32: 535–542, 1972.
Soyka, L.F.: Determinants of hepatic aminopyrine demethylase activity. Biochem. Pharmacol. 18: 1029–1038, 1969.
Wheeler, G.P. and Alexander, J.A.: Effects of nitrogen mustard and cyclophosphamide upon the synthesis of DNA in vivo and in cell free preparations. Canc. Res. 29: 98–109, 1969.
Wilson, J.G.: Teratogenic interaction of chemical agents in the rat. J. Pharmacol. Exp. Ther. 144: 420–436, 1964.
Wilson, J.G.: Embryological considerations in teratology. In J. G. Wilson and J. Warkany (eds.), Teratology Principles and Techniques, pp. 251–278, Chicago: The University of Chicago Press, 1965.
Wilson, J.T.: Alteration of normal development of drug metabolism by injection of growth hormone. Nature (London) 225: 861–863, 1970.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1974 Springer Science+Business Media New York
About this chapter
Cite this chapter
Gibson, J.E. (1974). Role of Biotransformation Reactions in Prenatal and Postnatal Chemical Toxicity. In: Simmons, I.L., Ewing, G.W. (eds) Methods in Radioimmunoassay, Toxicology, and Related Areas. Progress in Analytical Chemistry. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-3321-0_7
Download citation
DOI: https://doi.org/10.1007/978-1-4684-3321-0_7
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-3323-4
Online ISBN: 978-1-4684-3321-0
eBook Packages: Springer Book Archive